☰

Curtis R. Pickering, Ph.D. - Publications

Affiliations: 
2008 Cell Biology University of California, San Francisco, San Francisco, CA 
Area:
Oncology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

110/142 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zhao M, Wang T, Gleber-Netto FO, Chen Z, McGrail DJ, Gomez JA, Ju W, Gadhikar MA, Ma W, Shen L, Wang Q, Tang X, Pathak S, Raso MG, Burks JK, ... ... Pickering CR, et al. Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. Nature Communications. 15: 180. PMID 38167338 DOI: 10.1038/s41467-023-44239-2  0.333
2023 Pifer PM, Yang L, Kumar M, Xie T, Frederick M, Hefner A, Beadle B, Molkentine D, Molkentine J, Dhawan A, Abdelhakiem M, Osman AA, Leibowitz BJ, Myers JN, Pickering CR, et al. FAK drives resistance to therapy in HPV-negative head and neck cancer in a p53-dependent manner. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37819945 DOI: 10.1158/1078-0432.CCR-23-0964  0.34
2023 Coleman N, Marcelo KL, Hopkins JF, Khan NI, Du R, Hong L, Park E, Balsara B, Leoni M, Pickering C, Myers J, Heymach J, Albacker LA, Hong D, Gillison M, et al. Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma. Jco Precision Oncology. 7: e2200211. PMID 36603172 DOI: 10.1200/PO.22.00211  0.329
2022 Chahoud J, Zacharias NM, Pham R, Qiao W, Guo M, Lu X, Alaniz A, Segarra L, Martinez-Ferrer M, Gleber-Netto FO, Pickering CR, Rao P, Pettaway CA. Prognostic Significance of p16 and Its Relationship with Human Papillomavirus Status in Patients with Penile Squamous Cell Carcinoma: Results of 5 Years Follow-Up. Cancers. 14. PMID 36551510 DOI: 10.3390/cancers14246024  0.333
2022 Callahan SC, Kochat V, Liu Z, Raman AT, Divenko M, Schulz J, Terranova CJ, Ghosh AK, Tang M, Johnson FM, Wang J, Skinner HD, Pickering CR, Myers JN, Rai K. High enhancer activity is an epigenetic feature of HPV negative atypical head and neck squamous cell carcinoma. Frontiers in Cell and Developmental Biology. 10: 936168. PMID 35927986 DOI: 10.3389/fcell.2022.936168  0.372
2022 Shi Y, Xie T, Wang B, Wang R, Cai Y, Yuan B, Gleber-Netto FO, Tian X, Rodriguez-Rosario AE, Osman AA, Wang J, Pickering CR, Ren X, Sikora AG, Myers JN, et al. Mutant p53 drives an immune cold tumor immune microenvironment in oral squamous cell carcinoma. Communications Biology. 5: 757. PMID 35902768 DOI: 10.1038/s42003-022-03675-4  0.343
2021 Molkentine DP, Molkentine JM, Bridges KA, Valdecanas DR, Dhawan A, Bahri R, Hefner AJ, Kumar M, Yang L, Abdelhakiem M, Pifer PM, Sandulache V, Sheth A, Beadle BM, Thames HD, ... ... Pickering CR, et al. p16 Represses DNA Damage Repair via a Novel Ubiquitin-Dependent Signaling Cascade. Cancer Research. PMID 34965932 DOI: 10.1158/0008-5472.CAN-21-2101  0.326
2021 Gorur A, Patiño M, Shi T, Corrales G, Takahashi H, Rangel R, Gleber-Netto FO, Pickering C, Myers JN, Cata JP. Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor. Journal of Cellular Physiology. PMID 34038587 DOI: 10.1002/jcp.30421  0.322
2021 Chahoud J, Gleber-Netto FO, McCormick BZ, Rao P, Lu X, Guo M, Morgan MB, Chu RA, Martinez-Ferrer M, Eterovic AK, Pickering CR, Pettaway CA. Whole Exome Sequencing in Penile Squamous Cell Carcinoma Uncovers Novel Prognostic Categorization and Drug Targets Similar to Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33441293 DOI: 10.1158/1078-0432.CCR-20-4004  0.338
2020 Campbell BR, Chen Z, Faden DL, Agrawal N, Li RJ, Hanna GJ, Iyer NG, Boot A, Rozen SG, Vettore AL, Panda B, Krishnan NM, Pickering CR, Myers JN, Guo X, et al. The mutational landscape of early- and typical-onset oral tongue squamous cell carcinoma. Cancer. PMID 33146897 DOI: 10.1002/cncr.33309  0.328
2020 Uzunparmak B, Gao M, Lindemann A, Erikson K, Wang L, Lin E, Frank SJ, Gleber-Netto FO, Zhao M, Skinner HD, Newton JM, Sikora AG, Myers JN, Pickering CR. Caspase 8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic induced necroptosis. Jci Insight. PMID 33108350 DOI: 10.1172/jci.insight.139837  0.393
2020 Gleber-Netto FO, Neskey D, Costa AFM, Kataria P, Rao X, Wang J, Kowalski LP, Pickering CR, Dias-Neto E, Myers JN. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma. Cancer. PMID 32797678 DOI: 10.1002/Cncr.33101  0.454
2020 Facompre ND, Rajagopalan P, Sahu V, Pearson AT, Montone KT, James CD, Gleber-Netto FO, Weinstein GS, Jalaly J, Lin A, Rustgi AK, Nakagawa H, Califano JA, Pickering CR, White EA, et al. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models. International Journal of Cancer. PMID 32478869 DOI: 10.1002/Ijc.33125  0.458
2020 Molkentine JM, Molkentine DP, Bridges KA, Xie T, Yang L, Sheth A, Heffernan TP, Clump DA, Faust AZ, Ferris R, Myers JN, Frederick MJ, Mason KA, Meyn RE, Pickering CR, et al. Targeting DNA damage response in head and neck cancers through abrogation of cell cycle checkpoints. International Journal of Radiation Biology. 1-14. PMID 32073931 DOI: 10.1080/09553002.2020.1730014  0.307
2020 Chahoud J, Pham R, Guo M, Pickering CR, Qiao W, Khanna A, Netto F, Pettaway CA, Rao P. p16INK4a expression and survival outcomes in patients with penile squamous cell carcinoma: The M.D. Anderson Cancer Center Experience. Journal of Clinical Oncology. 38: 5-5. DOI: 10.1200/Jco.2020.38.6_Suppl.5  0.428
2020 Chahoud J, Netto F, Lazcano Segura R, Parra Cuentas ER, Lu X, Rao P, Wistuba II, Pickering CR, Pettaway CA. Tumor immune microenvironment alterations in penile squamous cell carcinoma using multiplex immunofluorescence and image analysis approaches. Journal of Clinical Oncology. 38: 4-4. DOI: 10.1200/Jco.2020.38.6_Suppl.4  0.417
2020 Abdelhakiem M, Bao R, Ferris RL, Pickering CR, Skinner HD. Association of radiation treatment failure in head and neck cancer with differential immune infiltrate. Journal of Clinical Oncology. 38: 6558-6558. DOI: 10.1200/Jco.2020.38.15_Suppl.6558  0.397
2020 Gleber-Netto FO, Gao M, Shen L, Wang J, Myers JN, Johnson FM, Pickering CR. Abstract B14: Variations in the proteasome activity are associated with human papilloma virus (HPV) gene expression and patient survival in HPV+ oropharyngeal tumors Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Aacrahns19-B14  0.424
2020 Facompre ND, Rajagopalan P, Pearson AT, Montone KT, James CD, Gleber-Netto FO, Nakagawa H, White EA, Rustgi AK, Califano JA, Pickering CR, Windle B, Morgan IM, Gimotty PA, Basu D. Abstract A01: HPV+ oral cancer PDXs identify prognostic utility for E2F target gene expression and mutation burden Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Aacrahns19-A01  0.451
2020 Facompre ND, Rajagopalan P, Sahu V, Gleber-Netto FO, Califano JA, Pickering CR, Gimotty PA, Basu D. Abstract A03: Predictors of HPV-related head and neck cancer progression identified through patient-derived models Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-A03  0.423
2020 Abdelhakiem MK, Yang L, Xie T, Kumar M, Molkentine D, Sheth A, Frederick M, Myers J, Pickering CR, Skinner HD. Abstract 6185: In vivo screening in HPV positive and HPV negative head and neck squamous cell carcinoma Cancer Research. 80: 6185-6185. DOI: 10.1158/1538-7445.Am2020-6185  0.438
2020 Jad Chahoud M, Netto F, Lazcano Segura R, Parrra Cuentes ER, Lu X, Priya Rao M, Wistuba II, Pickering CR, Pettaway* C. PD19-11 TUMOR IMMUNE MICROENVIRONMENT ALTERATIONS IN PENILE SQUAMOUS CELL CARCINOMA USING MULTIPLEX IMMUNOFLUORESCENCE AND IMAGE ANALYSIS APPROACHES The Journal of Urology. 203: e386. DOI: 10.1097/Ju.0000000000000862.011  0.357
2020 Chahoud J, Pham* R, Guo M, Pickering C, Qiao W, Khanna A, Netto F, Pettaway C, Yao P. MP11-16 P16INK4A EXPRESSION AND SURVIVAL OUTCOMES IN PATIENTS WITH PENILE SQUAMOUS CELL CARCINOMA The Journal of Urology. 203: e141-e142. DOI: 10.1097/Ju.0000000000000831.016  0.468
2019 Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Oral Oncology. 97: 56-61. PMID 31421472 DOI: 10.1016/J.Oraloncology.2019.07.028  0.36
2019 Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY. Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer. Journal of the National Cancer Institute. PMID 31124563 DOI: 10.1093/Jnci/Djz097  0.313
2019 Chahoud J, Pickering CR, Pettaway CA. Genetics and penile cancer: recent developments and implications. Current Opinion in Urology. PMID 31045928 DOI: 10.1097/Mou.0000000000000640  0.385
2019 Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Xie TX, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma. Head & Neck. PMID 30932264 DOI: 10.1002/Hed.25748  0.42
2019 Sambandam V, Frederick MJ, Shen L, Tong P, Rao X, Peng S, Singh R, Mazumdar T, Huang C, Li Q, Pickering CR, Myers JN, Wang J, Johnson FM. PDK1 mediates NOTCH1-mutated head and neck squamous carcinoma vulnerability to therapeutic PI3K/mTOR inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30770351 DOI: 10.1158/1078-0432.Ccr-18-3276  0.468
2019 Gleber-Netto FO, Rao X, Guo T, Xi Y, Gao M, Shen L, Erikson K, Kalu NN, Ren S, Xu G, Fisch KM, Akagi K, Seiwert T, Gillison M, Frederick MJ, ... ... Pickering CR, et al. Variations in HPV function are associated with survival in squamous cell carcinoma. Jci Insight. 4. PMID 30626753 DOI: 10.1172/Jci.Insight.124762  0.406
2019 Chahoud J, McCormick BZ, Netto F, Rao P, Pickering CR, Pettaway CA. Penile squamous cell carcinoma is genomically similar to other HPV-driven tumors. Journal of Clinical Oncology. 37: 505-505. DOI: 10.1200/Jco.2019.37.7_Suppl.505  0.472
2019 Le X, Pickering CR, Rubin ML, Netto F, Kies MS, Johnson FM, Lu C, Blumenschein GR, Bell D, Ginsberg LE, Wilson KF, Lewis J, Feng L, Wang J, Lee JJ, et al. Induction chemotherapy with and without erlotinib in patients with oral cavity squamous cell carcinomas (OCSCCs) amenable for surgical resection. Journal of Clinical Oncology. 37: 6067-6067. DOI: 10.1200/Jco.2019.37.15_Suppl.6067  0.305
2019 Basu D, Facompre ND, Gimotty PA, Rajagopalan P, Sahu V, Pearson AT, Califano JA, Netto F, Pickering CR. Identifying adverse molecular features of HPV+ head and neck cancers using patient-derived models. Journal of Clinical Oncology. 37: 6057-6057. DOI: 10.1200/Jco.2019.37.15_Suppl.6057  0.42
2019 Michikawa C, Torres-Saavedra PA, Silver NL, Harari PM, Kies MS, Rosenthal DI, Le Q, Jordan RC, Duose DY, Mallampati S, Trivedi S, Luthra R, Wistuba II, Lichtarge O, Foote RL, ... ... Pickering CR, et al. Evolutionary action score of TP53 analysis in pathologically high-risk HPV-negative head and neck cancer from a phase II clinical trial: NRG Oncology RTOG 0234. Journal of Clinical Oncology. 37: 6010-6010. DOI: 10.1200/Jco.2019.37.15_Suppl.6010  0.403
2019 Molkentine D, Bridges K, Sheth A, Valdecanas D, Pickering C, Skinner HD. Abstract 2919: p16 modulates a novel ubiquitin signaling cascade which regulates radioresponse and offers clinically relevant therapeutic targets in squamous cell carcinoma Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2919  0.434
2019 Zhao M, Wang T, Zhen C, Wang J, Pickering CR, Chen J, Myers JN, Zhou G. Abstract 5289: Gain-of-function mutant p53 predisposes head and neck keratinocytes and squamous cell carcinoma cells to replicative stress and genomic instability through minichromosome maintenance complex component 5 Cancer Research. 79: 5289-5289. DOI: 10.1158/1538-7445.Am2019-5289  0.477
2019 Gleber-Netto FO, Gao M, Rao X, Vellano CP, Marszalek JR, Wang J, Johnson FM, Pickering CR. Abstract 4942: Variations in HPV function are associated with patient outcome and identify new candidate therapeutic approaches Cancer Research. 79: 4942-4942. DOI: 10.1158/1538-7445.Am2019-4942  0.418
2019 Sambandam V, Shen L, Peng S, Mazumdar T, Pickering C, Myers J, Wang J, Frederick M, Johnson F. Abstract 3913: PDK1 drives susceptibility ofNOTCH1mutant head and neck squamous carcinoma to PI3K/mTOR pathway inhibition Cancer Research. 79: 3913-3913. DOI: 10.1158/1538-7445.Am2019-3913  0.47
2019 McCormick* B, Chahoud J, Netto F, Rao P, Pickering C, Pettaway C. MP73-11 PENILE SQUAMOUS CELL CARCINOMA IS GENOMICALLY SIMILAR TO OTHER HPV-DRIVEN TUMORS Journal of Urology. 201. DOI: 10.1097/01.Ju.0000557257.46397.22  0.45
2019 Takahashi Y, Gleber-Netto FO, Bell D, Roberts D, Abdelmeguid AS, Pickering C, Myers JN, Hanna EY. PFKFB2 as a Potential Survival Marker in Sinonasal Undifferentiated Carcinoma Skull Base Surgery. 80. DOI: 10.1055/S-0039-1679430  0.344
2018 Haddad RI, Massarelli E, Lee JJ, Lin HY, Hutcheson K, Lewis J, Garden AS, Blumenschein GR, William WN, Pharaon RR, Tishler RB, Glisson BS, Pickering C, Gold KA, Johnson FM, et al. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30596812 DOI: 10.1093/Annonc/Mdy549  0.377
2018 Clump DA, Pickering CR, Skinner HD. Predicting Outcome in Head and Neck Cancer: miRNAs with potentially big effects. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30413524 DOI: 10.1158/1078-0432.Ccr-18-3078  0.391
2018 Choi BK, Dayaram T, Parikh N, Wilkins AD, Nagarajan M, Novikov IB, Bachman BJ, Jung SY, Haas PJ, Labrie JL, Pickering CR, Adikesavan AK, Regenbogen S, Kato L, Lelescu A, et al. Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2. Proceedings of the National Academy of Sciences of the United States of America. PMID 30266789 DOI: 10.1073/Pnas.1806643115  0.348
2018 Ma J, Fu Y, Tu YY, Liu Y, Tan YR, Ju WT, Pickering CR, Myers JN, Zhang ZY, Zhong LP. Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma. Bmc Cancer. 18: 758. PMID 30041611 DOI: 10.1186/S12885-018-4481-8  0.418
2018 Kalu NN, Mazumdar T, Peng S, Tong P, Shen L, Wang J, Banerjee U, Myers JN, Pickering CR, Brunell D, Stephan CC, Johnson FM. Comprehensive pharmacogenomic profiling of human papillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora kinase inhibition in KMT2D mutants. Cancer Letters. PMID 29807113 DOI: 10.1016/J.Canlet.2018.05.029  0.468
2018 Campbell JD, Yau C, Bowlby R, Liu Y, Brennan K, Fan H, Taylor AM, Wang C, Walter V, Akbani R, Byers LA, Creighton CJ, Coarfa C, Shih J, Cherniack AD, ... ... Pickering CR, et al. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. Cell Reports. 23: 194-212.e6. PMID 29617660 DOI: 10.1016/J.Celrep.2018.03.063  0.469
2018 Abram TJ, Pickering CR, Lang AK, Bass NE, Raja R, Meena C, Alousi AM, Myers JN, McDevitt JT, Gillenwater AM, Vigneswaran N. Risk Stratification of Oral Potentially Malignant Disorders in Fanconi Anemia Patients Using Autofluorescence Imaging and Cytology-On-A Chip Assay. Translational Oncology. 11: 477-486. PMID 29481998 DOI: 10.1016/J.Tranon.2018.01.014  0.383
2018 Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, McLellan M, Bowlby R, Matthew T, Danilova L, Hegde AM, Kim J, et al. The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell. 33: 244-258.e10. PMID 29438696 DOI: 10.1016/J.Ccell.2018.01.003  0.389
2018 Sandulache VC, Michikawa C, Kataria P, Gleber-Netto FO, Bell D, Trivedi S, Rao X, Wang J, Zhao M, Jasser SA, Myers JN, Pickering CR. High-risk TP53 mutations are associated with extra nodal extension (ENE) in oral cavity squamous cell carcinoma (OSCC). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29330202 DOI: 10.1158/1078-0432.Ccr-17-0721  0.446
2018 Kumar M, Bridges K, Molkentine D, Yang L, Sheth A, Meyn R, Frederick M, Myers J, Pickering C, Skinner HD. Abstract 978: In vivo shRNA screening identifies synthetic cytotoxicity in CREBBP/EP300 mutant head and neck cancer Cancer Research. 78: 978-978. DOI: 10.1158/1538-7445.Am2018-978  0.506
2018 Mazumdar T, Kalu NN, Peng S, Tong P, Shen L, Wang J, Myers JN, Pickering CR, Brunell D, Stephan CC, Johnson FM. Abstract 4646: Pharmacogenomic screen identifies KMT2D mutations as a biomarker of sensitivity to Aurora kinase inhibition in head and neck and cervical squamous cell carcinoma Cancer Research. 78: 4646-4646. DOI: 10.1158/1538-7445.Am2018-4646  0.47
2018 Sambandam V, Shen L, Tong P, Peng S, Mazumdar T, Singh R, Pickering CR, Myers JN, Wang J, Frederick M, Johnson FM. Abstract 2977: PI3K/mTOR pathway inhibition induces Aurora B mediated cell death in NOTCH1 mutant head and neck squamous (HNSCC) cells Cancer Research. 78: 2977-2977. DOI: 10.1158/1538-7445.Am2018-2977  0.421
2018 Colbert L, Kumar M, Yang L, Molkentine D, Bridges K, Myers J, Xie T, Frederick M, Pickering C, Skinner H. In Vivo shRNA Screening Reveals Differential Radiosensitization Within HPV+ and HPV- Head and Neck Squamous Cell Carcinomas International Journal of Radiation Oncology*Biology*Physics. 102: S119. DOI: 10.1016/J.Ijrobp.2018.06.297  0.404
2017 Gadhikar MA, Zhang J, Shen L, Rao X, Wang J, Zhao M, Kalu NN, Johnson FM, Byers LA, Heymach J, Hittelman WN, Udayakumar D, Pandita RK, Pandita TK, Pickering CR, et al. CDKN2A/p16 deletion in head and neck cancer cells is associated with Cdk2 activation, replication stress, and vulnerability to Chk1 inhibition. Cancer Research. PMID 29229598 DOI: 10.1158/0008-5472.Can-17-2802  0.46
2017 Kalu NN, Mazumdar T, Peng S, Shen L, Sambandam V, Rao X, Xi Y, Li L, Qi Y, Gleber-Netto FO, Patel A, Wang J, Frederick MJ, Myers JN, Pickering CR, et al. Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines. Oncotarget. 8: 86369-86383. PMID 29156801 DOI: 10.18632/Oncotarget.21174  0.436
2017 Gleber-Netto FO, Zhao M, Trivedi S, Wang J, Jasser S, McDowell C, Kadara H, Zhang J, Wang J, William WN, Lee JJ, Nguyen ML, Pai SI, Walline HM, Shin DM, ... ... Pickering CR, et al. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma. Cancer. PMID 29053175 DOI: 10.1002/Cncr.31063  0.336
2017 Chen TW, Lee CC, Liu H, Wu CS, Pickering CR, Huang PJ, Wang J, Chang IY, Yeh YM, Chen CD, Li HP, Luo JD, Tan BC, Chan TEH, Hsueh C, et al. APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism. Nature Communications. 8: 465. PMID 28878238 DOI: 10.1038/S41467-017-00493-9  0.471
2017 Tanaka N, Patel AA, Tang L, Silver NL, Lindemann A, Takahashi H, Jaksik R, Rao X, Kalu NN, Chen TC, Wang J, Frederick MJ, Johnson FM, Gleber-Netto F, Fu S, ... ... Pickering CR, et al. Replication stress leading to apoptosis within the S-phase contributes to synergism between vorinostat and AZD1775 in HNSCC harboring high risk TP53 mutation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28790110 DOI: 10.1158/1078-0432.Ccr-17-0947  0.496
2017 Morris VK, Rao X, Pickering CR, Foo WC, Rashid A, Eterovic AK, Kim TB, Chen K, Wang J, Shaw K, Eng C. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal. Molecular Cancer Research : McR. PMID 28784613 DOI: 10.1158/1541-7786.Mcr-17-0060  0.477
2017 Skinner HD, Giri U, Yang LP, Kumar M, Liu Y, Story MD, Pickering CR, Byers LA, Williams MD, Wang J, Shen L, Yoo SY, Fan YH, Molkentine DP, Beadle BM, et al. Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28476872 DOI: 10.1158/1078-0432.Ccr-16-2586  0.388
2017 Chang KP, Wang CI, Pickering CR, Huang Y, Tsai CN, Tsang NM, Kao HK, Cheng MH, Myers JN. Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma. Head & Neck. PMID 28230921 DOI: 10.1002/Hed.24728  0.428
2017 Zhang M, Singh R, Peng S, Mazumdar T, Sambandam V, Shen L, Tong P, Li L, Kalu N, Pickering CR, Frederick M, Myers JN, Wang J, Johnson FM. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors. Cancer Letters. PMID 28126323 DOI: 10.1016/J.Canlet.2017.01.024  0.475
2017 Xie T, Parimi RL, Kumar MF, Yang LP, Wang J, Seth S, Alessandro C, Bristow CA, Robinson FS, Peoples MD, Skinner H, Myers JN, Pickering CR, Frederick MJ. Abstract IA12: An in vivo high throughput shRNA screening platform for identifying ways to target genomic alterations Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Aacrahns17-Ia12  0.449
2017 Chang K, Chen T, Pickering CR, Myers JN, Chang Y. Abstract IA10: Integrated omics analyses identify prognostic biomarkers of oral cavity squamous cell carcinoma in Taiwan Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Aacrahns17-Ia10  0.481
2017 Takahashi Y, Bell D, Gleber-Netto FO, Xie T, Roberts D, Pickering C, Myers JN, Hanna EY. Abstract 42: Identification of gene expression patterns distinguishing responders and non-responders to induction chemotherapy in sinonasal undifferentiated carcinoma Clinical Cancer Research. 23: 42-42. DOI: 10.1158/1557-3265.Aacrahns17-42  0.402
2017 Uzunparmak B, Lindemann A, Frederick MJ, Myers JN, Pickering CR. Abstract 04: Caspase-8 is a novel candidate driver gene in head and neck squamous cell carcinoma Clinical Cancer Research. 23: 4-4. DOI: 10.1158/1557-3265.Aacrahns17-04  0.508
2017 Pickering CR, Xie T, Kumar M, Parimi RL, Yang LP, Wang J, Seth S, Bristow CA, Carugo A, Robinson FS, Draetta GF, Skinner H, Frederick MJ, Myers JN. Abstract 415:In vivoshRNA library screening to identify novel targets for head and neck squamous cell carcinoma Cancer Research. 77: 415-415. DOI: 10.1158/1538-7445.Am2017-415  0.407
2017 Zhang M, Ratnakar S, Peng S, Tuhina M, Li S, Tong P, Pickering C, Myers JN, Wang J, Johnson FM. Abstract 3816: Mutations of the lim protein ajuba mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell cycle inhibitors Cancer Research. 77: 3816-3816. DOI: 10.1158/1538-7445.Am2017-3816  0.453
2017 Sambandam V, Shen L, Tong P, Mazumdar T, Pickering C, Myers JN, Wang J, Frederick M, Johnson FM. Abstract 2992: Identification ofNOTCH1inactivating mutation as a therapeutic vulnerability to PI3K/mTOR pathway inhibition in head and neck squamous cell carcinoma (HNSCC) Cancer Research. 77: 2992-2992. DOI: 10.1158/1538-7445.Am2017-2992  0.481
2017 Takahashi Y, Bell D, Netto F, Xie T, Roberts D, Pickering C, Myers J, Hanna E. Gene Expression Signature in Sinonasal Undifferentiated Carcinoma Journal of Neurological Surgery Part B: Skull Base. 78: S1-S156. DOI: 10.1055/S-0037-1600612  0.363
2016 Chitsazzadeh V, Coarfa C, Drummond JA, Nguyen T, Joseph A, Chilukuri S, Charpiot E, Adelmann CH, Ching G, Nguyen TN, Nicholas C, Thomas VD, Migden M, MacFarlane D, Thompson E, ... ... Pickering C, et al. Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates. Nature Communications. 7: 12601. PMID 27574101 DOI: 10.1038/Ncomms12601  0.378
2016 Skinner HD, Giri U, Yang L, Woo SH, Story MD, Pickering CR, Byers LA, Williams MD, El-Naggar A, Wang J, Diao L, Shen L, Fan YH, Molkentine DP, Beadle BM, et al. Proteomic profiling identifies PTK2/FAK as a driver of radioresistance in HPV negative head and neck cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27036135 DOI: 10.1158/1078-0432.Ccr-15-2785  0.434
2016 Takahashi Y, Lee J, Pickering C, Bell D, Jiffar TW, Myers JN, Hanna EY, Kupferman ME. Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head & Neck. PMID 26752332 DOI: 10.1002/Hed.24350  0.402
2016 Skinner HD, Giri U, Story MD, Wang J, Shen L, Yoo SY, Byers LA, Pickering CR, Myers J, Williams MD, Heymach J. Proteomic and mRNA expression analysis identifies PDL-1 expression as a marker of treatment failure in head and neck cancer. Journal of Clinical Oncology. 34: 6042-6042. DOI: 10.1200/Jco.2016.34.15_Suppl.6042  0.398
2016 Zhang M, Peng S, Mazumdar T, Sambandam V, Shen L, Tong P, Li L, Byers L, Pickering C, Frederick M, Myers JN, Wang J, Johnson FM. Abstract 4757: Identification of biomarkers that predict response of head and neck squamous cell carcinoma to mitotic inhibitors Cancer Research. 76: 4757-4757. DOI: 10.1158/1538-7445.Am2016-4757  0.477
2016 Johnson FM, Sambandam V, Shen L, Zhang M, Saigal R, Tong P, Mazumdar T, Byers LA, Pickering C, Myers JN, Wang J, Frederick M. Abstract 393: NOTCH1 inactivating mutation mediates sensitivity to PI3K/mTOR inhibitors in head and neck squamous cell carcinoma Cancer Research. 76: 393-393. DOI: 10.1158/1538-7445.Am2016-393  0.5
2015 Foy JP, Pickering CR, Papadimitrakopoulou VA, Jelinek J, Lin SH, William WN, Mitchell FT, Wang J, Lang W, Feng L, Zhang L, Kim ES, Fan YH, Hong WK, El-Naggar A, et al. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development. Cancer Prevention Research (Philadelphia, Pa.). PMID 26342026 DOI: 10.1158/1940-6207.Capr-14-0179  0.347
2015 Wang Y, Springer S, Mulvey CL, Silliman N, Schaefer J, Sausen M, James N, Rettig EM, Guo T, Pickering CR, Bishop JA, Chung CH, Califano JA, Eisele DW, Fakhry C, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas. Science Translational Medicine. 7: 293ra104. PMID 26109104 DOI: 10.1126/Scitranslmed.Aaa8507  0.385
2015 Woo SH, Yang LP, Chuang HC, Fitzgerald A, Lee HY, Pickering C, Myers JN, Skinner HD. Down-regulation of malic enzyme 1 and 2: Sensitizing head and neck squamous cell carcinoma cells to therapy-induced senescence. Head & Neck. PMID 25994759 DOI: 10.1002/Hed.24129  0.428
2015 Osman AA, Neskey DM, Katsonis P, Patel AA, Ward AM, Hsu TK, Hicks SC, McDonald TO, Ow TJ, Alves MO, Pickering CR, Skinner HD, Zhao M, Sturgis EM, Kies MS, et al. Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients. Cancer Research. 75: 1205-15. PMID 25691460 DOI: 10.1158/0008-5472.Can-14-2729  0.407
2015 Neskey DM, Osman AA, Ow TJ, Katsonis P, McDonald T, Hicks SC, Hsu TK, Pickering CR, Ward A, Patel A, Yordy JS, Skinner HD, Giri U, Sano D, Story MD, et al. Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer. Cancer Research. 75: 1527-36. PMID 25634208 DOI: 10.1158/0008-5472.Can-14-2735  0.434
2015 Sambandam V, Shen L, Zhang M, Saigal R, Byers LA, Pickering C, Myers JN, Wang J, Johnson FM. Abstract 417: Integrative drug sensitivity analysis of PI3K /mTOR pathway inhibitors in Head and Neck Squamous Cell Carcinoma (HNSCC) Cancer Research. 75: 417-417. DOI: 10.1158/1538-7445.Am2015-417  0.398
2015 Moorthy S, Saade R, Pickering C, Neskey D, Tanaka N, Zweidler-McKay P, Frederick M, Myers J. Abstract 3934: Restoration of NOTCH signaling in head and neck squamous cell carcinoma inhibits tumor growth and cell migratory abilities Cancer Research. 75: 3934-3934. DOI: 10.1158/1538-7445.Am2015-3934  0.488
2015 Skinner HD, Giri U, Yordy JS, Story MD, Wang J, Byers LA, Williams MD, El-Naggar AK, Woo SH, Yang LP, Fan Y, Pickering CR, Myers JN, Heymach JV. Abstract 3441: Proteomic profiling identifies PTK2/FAK as a targetable marker of radioresistance in head and neck cancer Cancer Research. 75: 3441-3441. DOI: 10.1158/1538-7445.Am2015-3441  0.493
2014 Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Saade RE, Tsai KY, Curry JL, Tetzlaff MT, Lai SY, Yu J, Muzny DM, Doddapaneni H, Shinbrot E, Covington KR, et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6582-92. PMID 25303977 DOI: 10.1158/1078-0432.Ccr-14-1768  0.425
2014 Pickering CR, Zhang J, Neskey DM, Zhao M, Jasser SA, Wang J, Ward A, Tsai CJ, Ortega Alves MV, Zhou JH, Drummond J, El-Naggar AK, Gibbs R, Weinstein JN, Wheeler DA, et al. Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3842-8. PMID 24874835 DOI: 10.1158/1078-0432.Ccr-14-0565  0.439
2014 Guerrero-Preston R, Michailidi C, Marchionni L, Pickering CR, Frederick MJ, Myers JN, Yegnasubramanian S, Hadar T, Noordhuis MG, Zizkova V, Fertig E, Agrawal N, Westra W, Koch W, Califano J, et al. Key tumor suppressor genes inactivated by "greater promoter" methylation and somatic mutations in head and neck cancer. Epigenetics : Official Journal of the Dna Methylation Society. 9: 1031-46. PMID 24786473 DOI: 10.4161/Epi.29025  0.423
2014 Bailey AM, Zhan L, Maru D, Shureiqi I, Pickering CR, Kiriakova G, Izzo J, He N, Wei C, Baladandayuthapani V, Liang H, Kopetz S, Powis G, Guo GL. FXR silencing in human colon cancer by DNA methylation and KRAS signaling. American Journal of Physiology. Gastrointestinal and Liver Physiology. 306: G48-58. PMID 24177031 DOI: 10.1152/Ajpgi.00234.2013  0.366
2014 Hah JH, Zhao M, Pickering CR, Frederick MJ, Andrews GA, Jasser SA, Fooshee DR, Milas ZL, Galer C, Sano D, William WN, Kim E, Heymach J, Byers LA, Papadimitrakopoulou V, et al. HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells. Head & Neck. 36: 1547-54. PMID 24123531 DOI: 10.1002/Hed.23499  0.405
2014 Guerrero-Preston R, Michailidi C, Marchionni L, Pickering C, Frederick M, Myers J, Yegnasubramanian S, Hadar T, Noordhuis M, Fertig E, Agrawal N, Westra W, Koch W, Califano J, Velculescu V, et al. Abstract 2482: Key tumor suppressor genes inactivated by promoter methylation and somatic mutations in head and neck cancer Cancer Research. 74: 2482-2482. DOI: 10.1158/1538-7445.Am2014-2482  0.431
2014 Takahashi Y, Pickering C, Gelbard A, Drummond J, Wheeler D, Kupferman M, Myers J, Hanna E. Genomic Characterization of Sinonasal Undifferentiated Carcinoma Journal of Neurological Surgery Part B: Skull Base. 75. DOI: 10.1055/S-0034-1370490  0.338
2013 Gadhikar MA, Sciuto MR, Alves MV, Pickering CR, Osman AA, Neskey DM, Zhao M, Fitzgerald AL, Myers JN, Frederick MJ. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53. Molecular Cancer Therapeutics. 12: 1860-73. PMID 23839309 DOI: 10.1158/1535-7163.Mct-13-0157  0.501
2013 Pickering CR, Shah K, Ahmed S, Rao A, Frederick MJ, Zhang J, Unruh AK, Wang J, Ginsberg LE, Kumar AJ, Myers JN, Hamilton JD. CT imaging correlates of genomic expression for oral cavity squamous cell carcinoma. Ajnr. American Journal of Neuroradiology. 34: 1818-22. PMID 23764725 DOI: 10.3174/Ajnr.A3635  0.392
2013 Mroz EA, Tward AD, Pickering CR, Myers JN, Ferris RL, Rocco JW. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer. 119: 3034-42. PMID 23696076 DOI: 10.1002/Cncr.28150  0.41
2013 Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond J, Cortez E, Xie TX, Zhang D, Chung W, Issa JP, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discovery. 3: 770-81. PMID 23619168 DOI: 10.1158/2159-8290.Cd-12-0537  0.476
2013 Pickering CR, Myers JN. Bcl-2 inhibition or FBXW7 mutation sensitizes solid tumor cells to HDAC inhibition in vitro but could prove difficult to validate in patients. Cancer Discovery. 3: 258-9. PMID 23475877 DOI: 10.1158/2159-8290.Cd-13-0019  0.36
2013 Loyo M, Li RJ, Bettegowda C, Pickering CR, Frederick MJ, Myers JN, Agrawal N. Lessons learned from next-generation sequencing in head and neck cancer. Head & Neck. 35: 454-63. PMID 22907887 DOI: 10.1002/Hed.23100  0.409
2013 Gadhikar MA, Sciuto MR, Ortega MVA, Pickering C, Monroe M, Osman A, Neskey D, Sturgis EM, Myers JN, Frederick MJ. Abstract 708: Overcoming the cisplatin resistance of HNSCC cells through Chk1/2 inhibition. Cancer Research. 73: 708-708. DOI: 10.1158/1538-7445.Am2013-708  0.49
2013 Fried D, Pickering C, Rao A, Hunter L, Shah K, Ahmed S, Frederick M, Zhang J, Unruh A, Wang J, Ginsberg L, Kumar A, Myers J, Court L, Hamilton J. SU-E-CAMPUS-I-06: Imaging Biomarkers of CT Textural Analysis Correlate to Genomic Expression in Oral Cavity Squamous Cell Carcinoma Medical Physics. 40: 377-378. DOI: 10.1118/1.4815172  0.359
2012 Sandulache VC, Skinner HD, Ow TJ, Zhang A, Xia X, Luchak JM, Wong LJ, Pickering CR, Zhou G, Myers JN. Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status. Cancer. 118: 711-21. PMID 21720999 DOI: 10.1002/Cncr.26321  0.492
2012 Saintigny P, Lang W, Jelinek J, Pickering CR, Feng L, Frederick MJ, Zhang L, Ren H, Lee JJ, Kim ES, Fan YH, El-Naggar AK, Hong WK, Myers J, Papadimitrakopoulou V, et al. New DNA methylation markers associated with oral cancer (OC) development (dvlpt). Journal of Clinical Oncology. 30: 5524-5524. DOI: 10.1200/Jco.2012.30.15_Suppl.5524  0.342
2011 Saintigny P, Jelinek J, Pickering CR, Lang W, Frederick MJ, Zhang L, Ren H, Papadimitrakopoulou V, Lee JJ, Kim ES, Fan YH, El-Naggar AK, Hong WK, Myers J, Issa JJ, et al. DNA methyltransferase-3B (DNMT3B) in oral cancer (OC) development. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1506. PMID 28023622 DOI: 10.1200/Jco.2011.29.15_Suppl.1506  0.308
2011 Sano D, Xie TX, Ow TJ, Zhao M, Pickering CR, Zhou G, Sandulache VC, Wheeler DA, Gibbs RA, Caulin C, Myers JN. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6658-70. PMID 21903770 DOI: 10.1158/1078-0432.Ccr-11-0046  0.471
2011 Zhao M, Sano D, Pickering CR, Jasser SA, Henderson YC, Clayman GL, Sturgis EM, Ow TJ, Lotan R, Carey TE, Sacks PG, Grandis JR, Sidransky D, Heldin NE, Myers JN. Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7248-64. PMID 21868764 DOI: 10.1158/1078-0432.Ccr-11-0690  0.407
2011 Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Treviño L, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (New York, N.Y.). 333: 1154-7. PMID 21798897 DOI: 10.1126/Science.1206923  0.46
2011 Sandulache VC, Ow TJ, Pickering CR, Frederick MJ, Zhou G, Fokt I, Davis-Malesevich M, Priebe W, Myers JN. Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer. 117: 2926-38. PMID 21692052 DOI: 10.1002/Cncr.25868  0.438
2010 Fordyce C, Fessenden T, Pickering C, Jung J, Singla V, Berman H, Tlsty T. DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions. Cancer Prevention Research (Philadelphia, Pa.). 3: 190-201. PMID 20028875 DOI: 10.1158/1940-6207.Capr-09-0229  0.633
2010 William WN, Nunez M, Gu X, Jacobs RW, Litvak AM, Pickering CR, Lee J, El-Naggar AK, Glisson BS, Myers J. Prognostic value of biomarkers in tissue microarrays (TMAs) of squamous cell carcinomas of the oral tongue (SCCOT). Journal of Clinical Oncology. 28: 5548-5548. DOI: 10.1200/Jco.2010.28.15_Suppl.5548  0.359
2006 Zhang J, Pickering CR, Holst CR, Gauthier ML, Tlsty TD. p16INK4a modulates p53 in primary human mammary epithelial cells. Cancer Research. 66: 10325-31. PMID 17079452 DOI: 10.1158/0008-5472.Can-06-1594  0.702
2005 Gauthier ML, Pickering CR, Miller CJ, Fordyce CA, Chew KL, Berman HK, Tlsty TD. p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue. Cancer Research. 65: 1792-9. PMID 15753376 DOI: 10.1158/0008-5472.Can-04-3507  0.638
2001 Venkatachalam S, Tyner SD, Pickering CR, Boley S, Recio L, French JE, Donehower LA. Is p53 haploinsufficient for tumor suppression? Implications for the p53+/- mouse model in carcinogenicity testing Toxicologic Pathology. 29: 147-154. PMID 11695551 DOI: 10.1080/019262301753178555  0.399
Low-probability matches (unlikely to be authored by this person)
2020 Amit M, Takahashi H, Dragomir MP, Lindemann A, Gleber-Netto FO, Pickering CR, Anfossi S, Osman AA, Cai Y, Wang R, Knutsen E, Shimizu M, Ivan C, Rao X, Wang J, et al. Loss of p53 drives neuron reprogramming in head and neck cancer. Nature. PMID 32051587 DOI: 10.1038/S41586-020-1996-3  0.297
2019 Pickering C, Kumar M, Bridges K, Xie T, Molkentine D, Sheth A, Yang L, Frederick M, Heffernan T, Seth S, Myers J, Skinner HD. Abstract 2925: Targeting histone acetyltransferase (HAT) function for synthetic cytotoxicity in CREBBP/EP300 mutant tumors Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2925  0.297
2022 Rodriguez CP, Kang H, Geiger JL, Burtness B, Chung CH, Pickering CR, Fakhry C, Le QT, Yom SS, Galloway TJ, Golemis E, Li A, Shoop J, Wong S, Mehra R, et al. Clinical Trial Development in TP53-Mutated Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Journal of the National Cancer Institute. PMID 36053203 DOI: 10.1093/jnci/djac163  0.288
2013 Wu X, Bhayani MK, Dodge CT, Nicoloso MS, Chen Y, Yan X, Adachi M, Thomas L, Galer CE, Jiffar T, Pickering CR, Kupferman ME, Myers JN, Calin GA, Lai SY. Coordinated targeting of the EGFR signaling axis by microRNA-27a*. Oncotarget. 4: 1388-98. PMID 23963114 DOI: 10.18632/Oncotarget.1239  0.284
2022 Le X, Gleber-Netto FO, Rubin ML, Qing Y, Du R, Kies M, Blumenschein G, Lu C, Johnson FM, Bell D, Lewis J, Zhang J, Feng L, Wilson K, Marcelo-Lewis K, ... ... Pickering CR, et al. Induction chemotherapy with or without erlotinib in patients with head and neck squamous cell carcinoma amenable for surgical resection. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35443062 DOI: 10.1158/1078-0432.CCR-21-3239  0.282
2022 Michikawa C, Torres-Saavedra PA, Silver NL, Harari PM, Kies MS, Rosenthal DI, Le QT, Jordan RC, Duose DY, Mallampati S, Trivedi S, Luthra R, Wistuba II, Osman AA, Lichtarge O, ... ... Pickering CR, et al. Evolutionary Action Score of Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234. Advances in Radiation Oncology. 7: 100989. PMID 36420184 DOI: 10.1016/j.adro.2022.100989  0.282
2018 Takahashi Y, Gleber-Netto F, Bell D, Amit M, Roberts D, Pickering C, Myers J, Hanna E. Activation of the TGF Beta Signaling Pathway in Nonresponders to Induction Chemotherapy in Sinonasal Undifferentiated Carcinoma Journal of Neurological Surgery Part B: Skull Base. 79: S1-S188. DOI: 10.1055/S-0038-1633455  0.281
2018 Sheth A, Molkentine D, Kumar, Yang L, Xie T, Fredrick M, Myers J, Meyn R, Pickering C, Skinner H. OA30) In Vivo Screening Identifies ESR1 as a Clinically Relevant Target for Radiosensitization In HNSCC International Journal of Radiation Oncology Biology Physics. 101. DOI: 10.1016/J.Ijrobp.2018.02.069  0.279
2021 Spiotto MT, Taniguchi CM, Klopp AH, Colbert LE, Lin SH, Wang L, Frederick MJ, Osman AA, Pickering CR, Frank SJ. Biology of the Radio- and Chemo-Responsiveness in HPV Malignancies. Seminars in Radiation Oncology. 31: 274-285. PMID 34455983 DOI: 10.1016/j.semradonc.2021.02.009  0.272
2021 Kumar M, Molkentine D, Molkentine J, Bridges K, Xie T, Yang L, Hefner A, Gao M, Bahri R, Dhawan A, Frederick MJ, Seth S, Abdelhakiem M, Beadle BM, Johnson F, ... ... Pickering CR, et al. Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function. Nature Communications. 12: 6340. PMID 34732714 DOI: 10.1038/s41467-021-26570-8  0.265
2015 Gu S, Posey JE, Yuan B, Carvalho CM, Luk HM, Erikson K, Lo IF, Leung GK, Pickering CR, Chung BH, Lupski JR. Mechanisms for the Generation of Two Quadruplications Associated with Split-Hand Malformation. Human Mutation. PMID 26549411 DOI: 10.1002/Humu.22929  0.259
2021 Gorur A, Patiño M, Takahashi H, Corrales G, Pickering CR, Gleber-Netto FO, Myers JN, Cata JP. Mu-opioid receptor activation promotes in vitro and in vivo tumor growth in head and neck squamous cell carcinoma. Life Sciences. 119541. PMID 33930368 DOI: 10.1016/j.lfs.2021.119541  0.256
2022 Michikawa C, Gopalakrishnan V, Harrandah AM, Karpinets TV, Garg RR, Chu RA, Park YP, Chukkapallia SS, Yadlapalli N, Erikson-Carter KC, Gleber-Netto FO, Sayour E, Progulske-Fox A, Chan EKL, Wu X, ... ... Pickering CR, et al. Fusobacterium is enriched in oral cancer and promotes induction of programmed death-ligand 1 (PD-L1). Neoplasia (New York, N.Y.). 31: 100813. PMID 35834946 DOI: 10.1016/j.neo.2022.100813  0.253
2022 Ghosh S, Mazumdar T, Xu W, Powell RT, Stephan C, Shen L, Shah PA, Pickering CR, Myers JN, Wang J, Frederick MJ, Johnson FM. Combined TRIP13 and Aurora kinase inhibition induces apoptosis in human papillomavirus-driven cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35972731 DOI: 10.1158/1078-0432.CCR-22-1627  0.24
2021 Knitz MW, Bickett TE, Darragh LB, Oweida AJ, Bhatia S, Van Court B, Bhuvane S, Piper M, Gadwa J, Mueller AC, Nguyen D, Nangia V, Osborne DG, Bai X, Ferrara SE, ... ... Pickering CR, et al. Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis. Journal For Immunotherapy of Cancer. 9. PMID 33883256 DOI: 10.1136/jitc-2020-001955  0.237
2021 Stewart CA, Gay CM, Ramkumar K, Cargill KR, Cardnell RJ, Nilsson MB, Heeke S, Park EM, Kundu ST, Diao L, Wang Q, Shen L, Xi Y, Zhang B, Della Corte CM, ... ... Pickering CR, et al. Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 34274504 DOI: 10.1016/j.jtho.2021.07.002  0.231
2022 Hsu TK, Asmussen JK, Koire AM, Choi BK, Gadhikar MA, Huh E, Lin CH, Konecki DM, Kim YW, Pickering C, Kimmel M, Donehower LA, Frederick MJ, Myers JN, Katsonis P, et al. A general calculus of fitness landscapes finds genes under selection in cancers. Genome Research. PMID 35301263 DOI: 10.1101/gr.275811.121  0.21
2023 Xiao G, Wang S, Rong R, Yang D, Zhang X, Zhan X, Bishop J, Wilhelm C, Zhang S, Pickering C, Kris M, Minna J, Xie Y. Deep Learning of Cell Spatial Organizations Identifies Clinically Relevant Insights in Tissue Images. Research Square. PMID 37461694 DOI: 10.21203/rs.3.rs-2928838/v1  0.209
2023 Wang S, Rong R, Zhou Q, Yang DM, Zhang X, Zhan X, Bishop J, Chi Z, Wilhelm CJ, Zhang S, Pickering CR, Kris MG, Minna J, Xie Y, Xiao G. Deep learning of cell spatial organizations identifies clinically relevant insights in tissue images. Nature Communications. 14: 7872. PMID 38081823 DOI: 10.1038/s41467-023-43172-8  0.206
2023 Zhang X, Gleber-Netto FO, Wang S, Jin KW, Yang DM, Gillenwater AM, Myers JN, Ferrarotto R, Pickering CR, Xiao G. A Deep Learning Onion Peeling Approach to Measure Oral Epithelium Layer Number. Cancers. 15. PMID 37568707 DOI: 10.3390/cancers15153891  0.204
2020 Stewart CA, Gay CM, Ramkumar K, Cargill KR, Cardnell RJ, Nilsson MB, Heeke S, Park EM, Kundu ST, Diao L, Wang Q, Shen L, Xi Y, Maria Della Corte C, Fan Y, ... ... Pickering CR, et al. SARS-CoV-2 infection induces EMT-like molecular changes, including ZEB1-mediated repression of the viral receptor ACE2, in lung cancer models. Biorxiv : the Preprint Server For Biology. PMID 32577652 DOI: 10.1101/2020.05.28.122291  0.197
2022 Rangel R, Pickering CR, Sikora AG, Spiotto MT. Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy. Frontiers in Immunology. 13: 840923. PMID 35154165 DOI: 10.3389/fimmu.2022.840923  0.186
2023 Zhang X, Gleber-Netto FO, Wang S, Martins-Chaves RR, Gomez RS, Vigneswaran N, Sarkar A, William WN, Papadimitrakopoulou V, Williams M, Bell D, Palsgrove D, Bishop J, Heymach JV, Gillenwater AM, ... ... Pickering CR, et al. Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia. Cancer Medicine. PMID 36721313 DOI: 10.1002/cam4.5478  0.147
2017 Radovich M, Pickering C, Felau I, Ha G, Zhang H, Jo H, Hoadley KA, Anur P, Zhang J, Mclellan M, Bowlby R, Matthew T, Danilova L, Hedge AM, Kim J, et al. AB007. OS02.01. The integrated genomic landscape of thymic epithelial tumors: a report by the TCGA research network Mediastinum. 1: AB007-AB007. DOI: 10.21037/med.2017.AB007  0.145
2022 Brenes DR, Nipper AJ, Tan MT, Gleber-Netto FO, Schwarz RA, Pickering CR, Williams MD, Vigneswaran N, Gillenwater AM, Sikora AG, Richards-Kortum RR. Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions. Oral Oncology. 135: 106232. PMID 36335817 DOI: 10.1016/j.oraloncology.2022.106232  0.098
2015 Pickering CR, Bast RC, Keyomarsi K. How will we recruit, train, and retain physicians and scientists to conduct translational cancer research? Cancer. 121: 806-16. PMID 25355050 DOI: 10.1002/Cncr.29033  0.056
1993 Pickering CR, Craig WA, Barker MF, Cocker J, Donohue PC, Vanrietvelde G. New High Yield, High Reliability Materials System for Silver Multilayer Construction Microelectronics International: An International Journal. 10: 14-17. DOI: 10.1108/eb044485  0.036
2014 Spangler S, Wilkins AD, Bachman BJ, Nagarajan M, Dayaram T, Haas P, Regenbogen S, Pickering CR, Comer A, Myers JN, Stanoi I, Kato L, Lelescu A, Labrie JJ, Parikh N, et al. Automated hypothesis generation based on mining scientific literature Proceedings of the Acm Sigkdd International Conference On Knowledge Discovery and Data Mining. 1877-1886. DOI: 10.1145/2623330.2623667  0.035
2015 Nagarajan M, Wilkins AD, Bachman BJ, Novikov IB, Bao S, Haas PJ, Terrón-Díaz ME, Bhatia S, Adikesavan AK, Labrie JJ, Regenbogen S, Buchovecky CM, Pickering CR, Kato L, Lisewski AM, et al. Predicting future scientific discoveries based on a networked analysis of the past literature Proceedings of the Acm Sigkdd International Conference On Knowledge Discovery and Data Mining. 2015: 2019-2028. DOI: 10.1145/2783258.2788609  0.033
1905 Pickering CR. Queries and Minor Notes Journal of the American Medical Association. 1302-1303. DOI: 10.1001/jama.1905.02500430066024  0.027
1993 Manca JV, De Schepper L, De Ceuninck W, D'Olieslager M, Stals LM, Barker MF, Pickering CR, Craig WA, Beyne E, Roggen J. In-situ Electrical Measurements on Thick Film Dielectrics Microelectronics International: An International Journal. 10: 5-11. DOI: 10.1108/Eb044494  0.023
2009 Pickering C. Unique training brings young scientists up to speed in translational research. Disease Models & Mechanisms. 2: 211. PMID 19407325 DOI: 10.1242/dmm.003202  0.013
Hide low-probability matches.